JP7496180B2 - 分層方法、および、分層装置 - Google Patents
分層方法、および、分層装置 Download PDFInfo
- Publication number
- JP7496180B2 JP7496180B2 JP2024500980A JP2024500980A JP7496180B2 JP 7496180 B2 JP7496180 B2 JP 7496180B2 JP 2024500980 A JP2024500980 A JP 2024500980A JP 2024500980 A JP2024500980 A JP 2024500980A JP 7496180 B2 JP7496180 B2 JP 7496180B2
- Authority
- JP
- Japan
- Prior art keywords
- subject
- threshold
- volume
- subjects
- score
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
- A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
- A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F18/00—Pattern recognition
- G06F18/20—Analysing
- G06F18/24—Classification techniques
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F18/00—Pattern recognition
- G06F18/20—Analysing
- G06F18/24—Classification techniques
- G06F18/243—Classification techniques relating to the number of classes
- G06F18/24317—Piecewise classification, i.e. whereby each classification requires several discriminant rules
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Social work or social welfare, e.g. community support activities or counselling services
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/06—Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
- G06Q10/063—Operations research, analysis or management
- G06Q10/0639—Performance analysis of employees; Performance analysis of enterprise or organisation operations
- G06Q10/06398—Performance of employee with respect to a job function
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- G06V2201/00—Indexing scheme relating to image or video recognition or understanding
- G06V2201/03—Recognition of patterns in medical or anatomical images
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Child & Adolescent Psychology (AREA)
- Data Mining & Analysis (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Artificial Intelligence (AREA)
- Developmental Disabilities (AREA)
- Physiology (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Evolutionary Computation (AREA)
- Social Psychology (AREA)
- Educational Technology (AREA)
- Theoretical Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Fuzzy Systems (AREA)
- Mathematical Physics (AREA)
- Neurosurgery (AREA)
- Signal Processing (AREA)
- Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210149360.2 | 2022-02-18 | ||
| CN202210149360.2A CN116662835A (zh) | 2022-02-18 | 2022-02-18 | 分层方法以及分层装置 |
| PCT/JP2022/046352 WO2023157447A1 (ja) | 2022-02-18 | 2022-12-16 | 分層方法、および、分層装置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2023157447A1 JPWO2023157447A1 (https=) | 2023-08-24 |
| JPWO2023157447A5 JPWO2023157447A5 (https=) | 2024-05-15 |
| JP7496180B2 true JP7496180B2 (ja) | 2024-06-06 |
Family
ID=87578022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500980A Active JP7496180B2 (ja) | 2022-02-18 | 2022-12-16 | 分層方法、および、分層装置 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240366132A1 (https=) |
| EP (1) | EP4393388A4 (https=) |
| JP (1) | JP7496180B2 (https=) |
| CN (5) | CN116662835A (https=) |
| TW (1) | TW202341175A (https=) |
| WO (1) | WO2023157447A1 (https=) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180190369A1 (en) | 2015-06-29 | 2018-07-05 | Ixico Technologies Limited | Methods, systems and tools for selecting subjects suffering from neurodegenerative disease |
| JP2020509036A (ja) | 2017-03-01 | 2020-03-26 | エイチディーエル セラピューティクス インコーポレイテッドHdl Therapeutics, Inc. | アルツハイマー病を予防的に防止し、その進行を遅らせ、または処置するための方法 |
| WO2020257159A1 (en) | 2019-06-17 | 2020-12-24 | Alzheon, Inc. | Methods for treating neurodegenerative disorders |
| JP2021029692A (ja) | 2019-08-26 | 2021-03-01 | Tdk株式会社 | 軽度認知障害判定システム |
| JP2021097988A (ja) | 2019-12-20 | 2021-07-01 | 株式会社Splink | 認知症リスクの提示システムおよび方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090270717A1 (en) * | 2008-04-25 | 2009-10-29 | Welch Allyn, Inc. | Apparatus and method for diagnosis of optically identifiable ophthalmic conditions |
| KR101734645B1 (ko) * | 2015-05-18 | 2017-05-11 | (주)에이엔티랩스 | 초기 알츠하이머 병 또는 경도 인지 장애 진단 방법 |
| CN106636330B (zh) * | 2016-09-21 | 2017-12-15 | 郁金泰 | 阿尔茨海默病的诊断和治疗药物 |
| GB201705044D0 (en) * | 2017-03-29 | 2017-05-10 | Neuro-Bio Ltd | Biomarker |
| AU2018359624A1 (en) * | 2017-10-31 | 2020-04-30 | Ge Healthcare Limited | Medical system for diagnosing cognitive disease pathology and/or outcome |
| WO2022071158A1 (ja) * | 2020-10-01 | 2022-04-07 | 富士フイルム株式会社 | 診断支援装置、診断支援装置の作動方法、診断支援装置の作動プログラム、認知症診断支援方法、並びに学習済み認知症所見導出モデル |
-
2022
- 2022-02-18 CN CN202210149360.2A patent/CN116662835A/zh active Pending
- 2022-12-16 WO PCT/JP2022/046352 patent/WO2023157447A1/ja not_active Ceased
- 2022-12-16 CN CN202280061563.4A patent/CN117940065B/zh active Active
- 2022-12-16 EP EP22926346.2A patent/EP4393388A4/en active Pending
- 2022-12-16 US US18/689,257 patent/US20240366132A1/en active Pending
- 2022-12-16 CN CN202411205852.4A patent/CN119128701A/zh active Pending
- 2022-12-16 CN CN202510309021.XA patent/CN120234705A/zh active Pending
- 2022-12-16 CN CN202510309023.9A patent/CN120234706A/zh active Pending
- 2022-12-16 TW TW111148389A patent/TW202341175A/zh unknown
- 2022-12-16 JP JP2024500980A patent/JP7496180B2/ja active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180190369A1 (en) | 2015-06-29 | 2018-07-05 | Ixico Technologies Limited | Methods, systems and tools for selecting subjects suffering from neurodegenerative disease |
| JP2020509036A (ja) | 2017-03-01 | 2020-03-26 | エイチディーエル セラピューティクス インコーポレイテッドHdl Therapeutics, Inc. | アルツハイマー病を予防的に防止し、その進行を遅らせ、または処置するための方法 |
| WO2020257159A1 (en) | 2019-06-17 | 2020-12-24 | Alzheon, Inc. | Methods for treating neurodegenerative disorders |
| JP2021029692A (ja) | 2019-08-26 | 2021-03-01 | Tdk株式会社 | 軽度認知障害判定システム |
| JP2021097988A (ja) | 2019-12-20 | 2021-07-01 | 株式会社Splink | 認知症リスクの提示システムおよび方法 |
Non-Patent Citations (2)
| Title |
|---|
| KIM, Gwang-Won et al.,A pilot study of brain morphometry following donepezil treatment in mild cognitive impairment: volume changes of cortical/subcortical regions and hippocampal subfields,SCIENTIFIC REPORTS,2020年,10:10912 |
| ZANDIFAR Azar et al.,MRI and cognitive scores complement each other to accurately predict Alzheimer's dementia 2 to 7 years before clinical onset,NeuroImage: Clinical,2020年,Vol.25 (2020) 102121 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117940065A (zh) | 2024-04-26 |
| US20240366132A1 (en) | 2024-11-07 |
| EP4393388A4 (en) | 2025-09-17 |
| CN120234706A (zh) | 2025-07-01 |
| WO2023157447A1 (ja) | 2023-08-24 |
| CN117940065B (zh) | 2025-06-24 |
| CN120234705A (zh) | 2025-07-01 |
| TW202341175A (zh) | 2023-10-16 |
| CN119128701A (zh) | 2024-12-13 |
| JPWO2023157447A1 (https=) | 2023-08-24 |
| EP4393388A1 (en) | 2024-07-03 |
| CN116662835A (zh) | 2023-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tsai et al. | Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds: a PiB-PET study | |
| Singer et al. | Pure autonomic failure: predictors of conversion to clinical CNS involvement | |
| Backhouse et al. | Early life risk factors for cerebrovascular disease: a systematic review and meta-analysis | |
| Carod-Artal et al. | Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study | |
| Wang et al. | Genotypes and phenotypes of DMD small mutations in Chinese patients with dystrophinopathies | |
| DSa et al. | Association between serum cystatin C and creatinine in chronic kidney disease subjects attending a tertiary health care centre | |
| Wehenkel et al. | Random forests based group importance scores and their statistical interpretation: application for Alzheimer's disease | |
| Bonazzi et al. | Comparison between ultrasound and genetic testing for the early diagnosis of polycystic kidney disease in Persian and Exotic Shorthair cats | |
| Lu et al. | Consistent abnormalities in metabolic patterns of Lewy body dementias | |
| Nestor et al. | Towards precision nephrology: the opportunities and challenges of genomic medicine | |
| Carnero Contentti et al. | Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting | |
| Moon et al. | Predictors of renal relapse in Korean patients with lupus nephritis who achieved remission six months following induction therapy | |
| JP7496180B2 (ja) | 分層方法、および、分層装置 | |
| Carnero Contentti et al. | How to avoid missing a diagnosis of neuromyelitis optica spectrum disorder | |
| WO2022221283A1 (en) | Profiling cell types in circulating nucleic acid liquid biopsy | |
| Carnero Contentti et al. | The real‐world applicability of the 2023 international myelin oligodendrocyte glycoprotein antibody‐associated disease criteria in a Latin American cohort | |
| Neuens et al. | Diagnostic yield of clinical exome sequencing in 868 children with neurodevelopmental disorders | |
| Erro et al. | Diagnosis versus classification of essential tremor: a research perspective | |
| Cipriano et al. | Systematic review on the role of lobar cerebral microbleeds in cognition | |
| Chen et al. | Performance of the Benton Judgment of Line Orientation test across patients with different types of dementia | |
| Lai et al. | The application of whole-exome sequencing in the early diagnosis of rare genetic diseases in children: a study from Southeastern China | |
| ten Dam et al. | Elucidation of the genetic cause in dutch limb girdle muscular dystrophy families: a 27-year’s journey | |
| CN113611412A (zh) | 一种t2dm引起冠心病风险的预测方法、装置及系统 | |
| Sun et al. | The neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with neuromyelitis optica spectrum disorders and multiple sclerosis | |
| Scirpa et al. | Clinical translation of genetic testing in TTR Amyloidosis. genotype-phenotype correlations, management of asymptomatic carriers and familial screening |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240301 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240301 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20240301 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240402 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240424 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240507 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240520 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7496180 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |